Kutatási jelek – Signal Engine

• From hematuria warning to precision immunotherapy: an AI-assisted cross-platform analysis of bladder cancer information on social media — Bladder cancer
• Transgene and Nec Report 100% Three-Year Disease-Free — Head and neck squamous cell carcinoma
• Curcumin Blocks Fn-Driven Esophageal Cancer (2026) — Esophageal cancer
• 18F-FDG PET/CT metabolic network connectivity in clinical staging of diffuse large B-cell lymphoma — Diffuse large B-cell lymphoma
• Synthetic consensus DNA vaccines against Merkel cell polyomavirus large and small T antigens induce robust polyfunctional T cell responses — Merkel cell carcinoma
• Prediction model for survival outcome in patients with acute myeloid leukemia: a multicenter prospective cohort study from Thai Acute Leukemia Working Group — Acute myeloid leukemia
• Tackling drug discovery challenges in cancer research — Gastrointestinal stromal tumor
• Frontiers | Editorial: Emerging targeted and immunotherapeutic strategies in oncology: from solid tumors to hematologic malignancies — Acute lymphoblastic leukemia
• PD-1/PD-L1 inhibitors combined with chemotherapy as first-line treatment for advanced biliary tract cancer: a systematic review and meta-analysis — Cholangiocarcinoma
• Case Report: Iparomlimab and Tuvonralimab-based therapy for epithelioid malignant peritoneal mesothelioma: a three-case series — Melanoma
• The impact of chemoimmunotherapy on primary cold agglutinin disease and Waldenström macroglobulinemia-associated cold agglutinin syndrome — Waldenstrom macroglobulinemia
• Targeting bromodomain and extra-terminal proteins reprograms macrophages and inhibits breast cancer progression — Breast cancer
• Many Patients with Metastatic NSCLC Remain Untreated Despite Therapeutic Advances — NSCLC
• Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC — NSCLC
• Breaking the Amendment Cycle: How Agentic AI Enables Smarter Clinical Trial Design and Operations — Gastrointestinal stromal tumor
• Standard breast cancer classification may overlook important differences — Breast cancer
• A single‑cell atlas of multiple myeloma defines malignant archetypes and proliferative states — Multiple myeloma
• Developing personas for nutritional self-management in nasopharyngeal carcinoma patients: a qualitative study based on the Fogg Behavior Model — Nasopharyngeal carcinoma
• EGFR-Mutated NSCLC: Integrating Emerging ELCC Data Into Treatment Sequencing — NSCLC
• Ultra-Processed Foods Linked to 30% Higher Prostate Cancer Risk — Prostate cancer